What is Kappa myelom?

Kappa myeloma is a type of cancer that affects plasma cells found in the bone marrow. These cells become abnormal or mutated and grow from control. Healthy plasma cells produce immunoglobins, which are antibodies that help the body fight disease and cancer. Myelom Kappa is distinguished as abnormal plasma cells begin to produce and distribute changed immunoglobin containing protein Kappa.

Normal plasma cells produce a wide range of immunoglobins that help protect the body from many pathogens, cancer cells and other foreign bodies. In patients with myeloma Kappa, only one type creates. This altered immunoglobin contains a protein called Kappa Light Protein. Patients with this condition may significantly reduce immune function and the protein can concentrate in the blood, leading to kidney failure. Those with myeloma kappa are exposed to an increased risk of kidney failure compared to those suffering from other types of myeloma or RakovIna blood.

For myelom Kappa, there is usually no medicine. Chemotherapy or radiation may prolong life, but most patients die from the diagnosis within ten years. In general, this affects the large bones of the body and can cause a wide range of symptoms. Patients with myeloma are an increased risk of osteoporosis, fractures and other bone disorders of timely onset. Other symptoms may include fatigue, shortness of breath, arm pain, legs or backs and symptoms of kidney failure, such as urination problems, urination pain, constipation, nausea, vomiting and lower back pain.

patients with myeloma Kappa are also threatened by reduced immune function, leading to much higher susceptibility to secondary diseases and infections. Cancer treatment may further reduce the immune function. Those with a compromised immune system should avoid large groups, where it is easier to spread and often wash their hands.

Although usually myeloma drugs have taken a long way and medicines are in development that can drastically increase the life of patients and quality of life during the disease. Medicines can be used to slow down the course of the disease and to reduce pain. Separate drugs may also be needed to improve kidney function and strengthen the immune system to avert further diseases.

Kappa myeloma is usually diagnosed with blood tests, urine protein tests and bone marrow testing. Other samples can be taken to see if Kappa's immunoglobin protein is present. Treatment usually starts immediately with a specialist known as a hematologist-oncologist. The total life expectancy after diagnosis may depend on several factors, including the progression of the disease and the overall age and health of the patient.

Sometimes myelom gets into remission. This is that there are few or no cancer cells and symptoms may no longer be present. Although this happens, myeloma is generally considered incurable,Because most patients experience cancer at a certain point.